Biocon Biologics Inc.
5 drugs in NADAC|2 Generic,3 Brand
Biocon Biologics Inc. lists 5 NDCs in the CMS NADAC file (2 generic, 3 brand), at an average NADAC of $649.94 per unit, with a week-over-week move of -0.1% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
5
2G / 3B
Avg Price / Unit
$649.9392
$5.93 – $3185.94
Avg 7d Change
-0.07%
Across 4 drugs with changes
7d Activity
of 5 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Frequently Asked Questions
How many drugs does Biocon Biologics Inc. make?
Biocon Biologics Inc. lists 5 NDCs in the CMS NADAC file — 2 generic and 3 brand products.
What is the average price of Biocon Biologics Inc. drugs?
The average NADAC across Biocon Biologics Inc.'s portfolio is $649.9392 per unit, ranging from $5.9252 to $3185.9367.
What types of drugs does Biocon Biologics Inc. make?
Biocon Biologics Inc. makes drugs across 2 FDA pharmacologic classes. The most common by NDC count are Insulin Analog (4), Leukocyte Growth Factor (1).
Has Biocon Biologics Inc. had any drug recalls?
No FDA enforcement recalls are matched to Biocon Biologics Inc. in the openFDA feed.
How has Biocon Biologics Inc.'s pricing changed recently?
Over the past 7 days, 0 Biocon Biologics Inc. products rose and 4 fell, with a portfolio-wide average change of -0.1%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
FULPHILA 6 MG/0.6 ML SYRINGE pegfilgrastim-jmdb | $3185.9367 per ML | — |
SEMGLEE (YFGN) 100 UNIT/ML VL insulin glargine-yfgn | $25.9784 per ML | -0.02% |
SEMGLEE (YFGN) 100 UNIT/ML PEN insulin glargine-yfgn | $25.7695 per ML | -0.09% |
INSULIN GLARGINE-YFGN U100 VL insulin Glargine-yfgn | $6.0864 per ML | -0.12% |
INSULIN GLARGINE-YFGN U100 PEN insulin Glargine-yfgn | $5.9252 per ML | -0.06% |